These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 17236606)

  • 1. Medical care and alcohol use after testing hepatitis C antibody positive at STD clinic and HIV test site screening programs.
    Mark KE; Murray PJ; Callahan DB; Gunn RA
    Public Health Rep; 2007; 122(1):37-43. PubMed ID: 17236606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of health insurance limits the benefits of hepatitis C virus screening: insights from the National Health and Nutrition Examination Hepatitis C follow-up study.
    Ditah I; Al Bawardy B; Gonzalez HC; Saberi B; Ditah C; Kamath PS; Charlton M
    Am J Gastroenterol; 2015 Aug; 110(8):1126-33. PubMed ID: 25756239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Public health clinic-based hepatitis C testing and linkage to care in Baltimore.
    Falade-Nwulia O; Mehta SH; Lasola J; Latkin C; Niculescu A; O'Connor C; Chaulk P; Ghanem K; Page KR; Sulkowski MS; Thomas DL
    J Viral Hepat; 2016 May; 23(5):366-74. PubMed ID: 26840570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The costs and impacts of testing for hepatitis C virus antibody in public STD clinics.
    Honeycutt AA; Harris JL; Khavjou O; Buffington J; Jones TS; Rein DB
    Public Health Rep; 2007; 122 Suppl 2(Suppl 2):55-62. PubMed ID: 17542455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benefits and adverse effects of hepatitis C screening: early results of a screening program.
    Trepka MJ; Zhang G; Leguen F; Obiaja K; Malow RM; De La Rosa M
    J Public Health Manag Pract; 2007; 13(3):263-9. PubMed ID: 17435493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The disposition of hepatitis C antibody-positive patients in an urban hospital.
    Putka B; Mullen K; Birdi S; Merheb M
    J Viral Hepat; 2009 Nov; 16(11):814-21. PubMed ID: 19842281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Burden of hepatitis C virus disease and access to hepatitis C virus services in people who inject drugs in India: a cross-sectional study.
    Solomon SS; Mehta SH; Srikrishnan AK; Solomon S; McFall AM; Laeyendecker O; Celentano DD; Iqbal SH; Anand S; Vasudevan CK; Saravanan S; Lucas GM; Kumar MS; Sulkowski MS; Quinn TC
    Lancet Infect Dis; 2015 Jan; 15(1):36-45. PubMed ID: 25486851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guidelines for laboratory testing and result reporting of antibody to hepatitis C virus. Centers for Disease Control and Prevention.
    Alter MJ; Kuhnert WL; Finelli L;
    MMWR Recomm Rep; 2003 Feb; 52(RR-3):1-13, 15; quiz CE1-4. PubMed ID: 12585742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low prevalence of hepatitis C virus antibody in men who have sex with men who do not inject drugs.
    Buffington J; Murray PJ; Schlanger K; Shih L; Badsgard T; Hennessy RR; Wood R; Weisfuse IB; Gunn RA
    Public Health Rep; 2007; 122 Suppl 2(Suppl 2):63-7. PubMed ID: 17542456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serological prevalence of hepatitis B virus and hepatitis C virus infection in the elderly population: Polish nationwide survey--PolSenior.
    Hartleb M; Gutkowski K; Zejda JE; Chudek J; Więcek A
    Eur J Gastroenterol Hepatol; 2012 Nov; 24(11):1288-95. PubMed ID: 22864260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical pathways for patients with newly diagnosed hepatitis C - what actually happens.
    Irving WL; Smith S; Cater R; Pugh S; Neal KR; Coupland CA; Ryder SD; Thomson BJ; Pringle M; Bicknell M; Hippisley-Cox J
    J Viral Hepat; 2006 Apr; 13(4):264-71. PubMed ID: 16611193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison Stratagems of Post-Screening Management of Anti-HCV-Positive Community Residents: Simple Notification, Active Referral, or Accessible Medical Care.
    Kuo YH; Chen PF; Wang JH; Chang KC; Kee KM; Tsai MC; Lin CY; Lin SC; Tsai LS; Chen SC; Lu SN
    PLoS One; 2015; 10(5):e0126031. PubMed ID: 25970487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of a Hepatitis C screening program at a large urban VA medical center.
    Groom H; Dieperink E; Nelson DB; Garrard J; Johnson JR; Ewing SL; Stockley H; Durfee J; Jonk Y; Willenbring ML; Ho SB
    J Clin Gastroenterol; 2008 Jan; 42(1):97-106. PubMed ID: 18097298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of screening criteria to identify persons with hepatitis C virus infection among sexually transmitted disease clinic clients: results from the San Diego Viral Hepatitis Integration Project.
    Gunn RA; Murray PJ; Brennan CH; Callahan DB; Alter MJ; Margolis HS
    Sex Transm Dis; 2003 Apr; 30(4):340-4. PubMed ID: 12671556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated Hepatitis C Testing and Linkage to Care at a Local Health Department Sexually Transmitted Disease Clinic: Determining Essential Resources and Evaluating Outcomes.
    Rhea S; Seña AC; Hilton A; Hurt CB; Wohl D; Fleischauer A
    Sex Transm Dis; 2018 Apr; 45(4):229-232. PubMed ID: 29465696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of screening for hepatitis C virus infection based on risk factors.
    Mallette C; Flynn MA; Promrat K
    Am J Gastroenterol; 2008 Jan; 103(1):131-7. PubMed ID: 17894850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary Care Perspectives on Hepatitis C Virus Screening, Diagnosis and Linking Patients to Appropriate Care.
    Lebovics E; Torres R; Porter LK
    Am J Med; 2017 Feb; 130(2):S1-S2. PubMed ID: 28087291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of elevated ALT values, HBsAg, and anti-HCV in the primary care setting and evaluation of guideline defined hepatitis risk scenarios.
    Wolffram I; Petroff D; Bätz O; Jedrysiak K; Kramer J; Tenckhoff H; Berg T; Wiegand J;
    J Hepatol; 2015 Jun; 62(6):1256-64. PubMed ID: 25617500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV infection and risk, prevention, and testing behaviors among injecting drug users -- National HIV Behavioral Surveillance System, 20 U.S. cities, 2009.
    Broz D; Wejnert C; Pham HT; DiNenno E; Heffelfinger JD; Cribbin M; Krishna N; Teshale EH; Paz-Bailey G;
    MMWR Surveill Summ; 2014 Jul; 63(6):1-51. PubMed ID: 24990587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HBsAg and anti-HCV screening in elderly hospitalized patients of a German tertiary referral centre.
    Kant J; Kratzsch J; Maier M; Liebert UG; Berg T; Wiegand J
    Z Gastroenterol; 2016 Mar; 54(3):231-7. PubMed ID: 27043886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.